OptionsBuddy.com - News Article

Search this site:

About Us

Glossary

Frequently Asked Questions (FAQ)

Advertise on OptionsBuddy.com

Quote | Options | News | Analyst Ratings

Salix Pharmaceuticals Ltd (SLXP)

Quote as of 4:00 PM ET 09/02/2010 (NASDAQ GS)

Last: 39.63

Change: $0.53

Percent Change: 1.36

Volume: 556,062

Salix Pharmaceuticals, Ltd. (Salix) is a specialty pharmaceutical company dedicated to acquiring, developing and commercializing prescription drugs used in the treatment of a variety of gastrointestinal diseases, which are affecting the digestive tract. The Company?s products include XIFAXAN, MOVIPREP, OSMOPREP, VISICOL, APRISO, METOZOLV, AZASAN, ANUSOL-HC, PROCTOCORT cream, PEPCID, Oral Suspension DIURIL and COLAZAL. The Company?s products under development include Rifaximin, Crofelemer, Balsalazide disodium tablet and Budesonide foam.

Oops! We are unable to retrieve this news article.

- Sponsored Advertisement -

OptionsBuddy.com's covered call data is provided for information purposes only and should not be used or construed as an indicator of future performance. The information is not a solicitation, an offer to buy or sell, or a recommendation for any security. OptionsBuddy.com does not guarantee the accuracy or completeness of the information, or the suitability or potential value of any particular investment. Request a prospectus before investing. The term 'play' refers to placing a trade order. Returns on Investment (ROI) are based upon the option bid and the stock last. OTM ROI's do not take into account commission costs or loss of profit from options being excersized.